Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.

Total number of publications: 7,082

Enter a faculty name:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

First Prev 1 2 3 4 5 6 7 8 9 10 Next Last
  • Chu, Y., Lee, F., Hamby, C., Misarti, J., Hang, B., Ayello, J., . . . Cairo, M. (2016). Regulation of cytokine release and anti-tumor effect of anti-CD20 CAR modified expanded natural killer cells by Alt-803, an IL-15 superagonist. Experimental Hematology, 44(9), S64. doi:10.1016/j.exphem.2016.06.107

  • Chu, Y., Yahr, A., Ayello, J., Van de Ven, C., & Cairo, M. (2014). Therapeutic effects of romidepsin, a histone deacetylase inhibitor (HDACI), alone and in combination with natural killer cells against pediatric Burkitt lymphoma. Pediatric Blood and Cancer, 61(S2), S138.

  • Chu, Y., Yahr, A., Ayello, J., Van De Ven, C., Barth, M., Czuczman, M., & Cairo, M. S. (2014). Anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer (NK) cells significantly mediate rituximab sensitive and resistant Burkitt lymphoma (BL) regression and improve survival in human BL xenografted NSG mice. Biology of Blood and Marrow Transplantation, 20(2 Suppl), S257.

  • Chu, Y., Yahr, A., Cheng, B., Hang, B., Ayello, J., Barth, M., & Cairo, M. S. (2016). Enhanced in-vitro and in-vivo targeting of rituximab sensitive and resistant Burkitt lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer cells in combination with a histone deacetylase inhibitor, romidepsin. Biology of Blood and Marrow Transplantation, 22(3), S392. doi:10.1016/j.bbmt.2015.11.915

  • Chu, Y., Yahr, A., Cheng, B., Hang, B., Ayello, J., Barth, M., & Cairo, M. S. (2016). Enhanced in-vitro and in-vivo targeting of rituximab sensitive and resistant Burkitt lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer cells in combination with a histone deacetylase inhibitor, romidepsin. Pediatric Blood & Cancer, 63(Suppl S1), S96.

  • Cohen, B., Murray, M., Jia, H., Jackson, O., Saiman, L., Neu, N., . . . Hutcheon, G. (2016). Is hand hygiene frequency associated with the onset of outbreaks in pediatric long-term care? American Journal of Infection Control, 44(12), 1492-1494. doi:10.1016/j.ajic.2016.06.022

  • Cunningham, A., Frazier, D., Marriage, B., Mofidi, S., Ogata, B., Rohr, F., . . . Yannicelli, S. (2016). Role of medical food in MMA. Genetics in Medicine, 18(4), 413-414. doi:10.1038/gim.2016.11

  • Cvetkovic, D., Lafaro, R., Giamelli, J., Suvro, S., Erb, M., & Yaghoubian, S. (2016). Quadruple vessel coronary artery bypass grafting in a 14-year-old child with plasminogen activator inhibitor-1 4G/4G gene polymorphism. Seminars in Cardiothoracic and Vascular Anesthesia, 20(2), 163-167. doi:10.1177/1089253216631426

  • Cvetkovic, D., Ramzy, W., Vitale, S., Malekan, R., & Warsy, I. (2014). Successful one-lung ventilation in a patient with the fontan circulation undergoing thoracoscopic procedure. Seminars in Cardiothoracic and Vascular Anesthesia, 18(4), 379-381. doi:10.1177/1089253214542252

  • de Kock, L., Wang, Y. C., Revil, T., Badescu, D., Rivera, B., Sabbaghian, N., . . . Sandoval C. (2016). High-sensitivity sequencing reveals multi-organ somatic mosaicism causing DICER1 syndrome. Journal of Medical Genetics, 53(1), 43-52. doi:10.1136/jmedgenet-2015-103428

  • Dejhalla, M., Lahage, N., Parvez, B., Brumberg, H. L., & La Gamma, E. F. (2015). Early postnatal growth in a subset of convalescing extremely low birth weight neonates - approximating the "index fetus" ex utero. Journal of Pediatric Gastroenterology and Nutrition, 61(3), 361-366. doi:10.1097/MPG.0000000000000750

  • Del Pozzi, A., Medow, M., & Stewart, J. (2014). Blunted cerebrovascular response to exogenous nitric oxide in POTS. FASEB Journal, 28(1 Suppl.), 1068.12.

  • Del Pozzi, A., Medow, M., & Stewart, J. (2014). Oscillatory cerebral blood flow in postural tachycardia syndrome. FASEB Journal, 28(1 Suppl.), 1183.7

  • Del Pozzi, A. T., Pandey, A., Medow, M. S., Messer, Z. R., & Stewart, J. M. (2014). Blunted cerebral blood flow velocity in response to a nitric oxide donor in postural tachycardia syndrome. American Journal of Physiology. Heart and Circulatory Physiology, 307(3), H397-H404. doi:10.1152/ajpheart.00194.2014

  • Del Pozzi, A. T., Schwartz, C. E., Tewari, D., Medow, M. S., & Stewart, J. M. (2014). Reduced cerebral blood flow with orthostasis precedes hypocapnic hyperpnea, sympathetic activation, and postural tachycardia syndrome. Hypertension, 63(6), 1302-1308. doi:10.1161/HYPERTENSIONAHA.113.02824

  • Dohare, P., Zia, M. T., Ahmed, E., Ahmed, A., Yadala, V., Schober, A. L., . . . Ballabh, P. (2016). AMPA-kainate receptor inhibition promotes neurologic recovery in premature rabbits with intraventricular hemorrhage. The Journal of Neuroscience, 36(11), 3363-3377. doi:10.1523/JNEUROSCI.4329-15.2016

  • Dozor, A. J., & Amler, R. W. (2013). Children's environmental health. Journal of Pediatrics, 162(1), 6-7.e2. doi:10.1016/j.jpeds.2012.10.004

  • Edwards, K., Towle, P. O., & Levitz, B. (2014). Incorporating life course theory and social determinants of health into the LEND curriculum. Maternal and Child Health Journal, 18(2), 431-442. doi:10.1007/s10995-013-1283-0

  • El-Mallawany, N. K., & Cairo, M. S. (2015). Advances in the diagnosis and treatment of childhood and adolescent B-cell non-Hodgkin lymphoma. Clinical Advances in Hematology & Oncology : H&O, 13(2), 113-123. This material can be found here.

  • El-Mallawany, N. K., Day, N., Ayello, J., Van De Ven, C., Conlon, K., Fermin, D., . . . Cairo, M. S. (2015). Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma. European Journal of Cancer, 51(1), 92-100. doi:10.1016/j.ejca.2014.10.017

  • El-Mallawany, N. K., Kamiyango, W., Slone, J. S., Villiera, J., Kovarik, C. L., Cox, C. M., . . . Mehta, P. S. (2016). Clinical factors associated with long-term complete remission versus poor response to chemotherapy in HIV-infected children and adolescents with Kaposi sarcoma receiving bleomycin and vincristine: A retrospective observational study. PLoS One, 11(4) [Article e0153335]. doi:10.1371/journal.pone.0153335

  • El-Mallawany, N. K., Van Vlierberghe, P., Ferrando, A. A., Lim, M. S., & Cairo, M. S. (2013). T-cell malignancies in children and adolescents: State of the clinical and biological science. In F. Foss (Ed.), T-cell lymphomas (pp. 179-216). New York, NY: Humana Press.

  • El-Mallawany, N., Kamiyango, W., Villiera, J., Kovarik, C., Schutze, G., . . . Mehta, P. (2014). Kaposi sarcoma in HIV-infected children: A novel clinical staging classification determines risk stratification. Pediatric Blood and Cancer, 61(S2), S158.

  • Evans, S. D., Mellins, C. A., Leu, C. S., Warne, P., Elkington, K. S., Dolezal, C., . . . Bamji, M. (2015). HIV treatment adherence measurement and reporting concordance in youth with perinatally acquired HIV infection and their caregivers. AIDS Patient Care and STDs, 29(1), 43-51. doi:10.1089/apc.2014.0058

  • Faustino, E. V., Hanson, S., Spinella, P. C., Tucci, M., O'Brien, S. H., Nunez, A. R., . . . Li, S. (2014). A multinational study of thromboprophylaxis practice in critically ill children, Critical Care Medicine, 42(5), 1232-1240. doi:10.1097/CCM.0000000000000147

First Prev 1 2 3 4 5 6 7 8 9 10 Next Last